The past year saw US FDA and industry work hard and fast to prepare for what looks like an inevitable boom in the digital-health sector. According to interviews, the time is ripe for adoption of mobile health apps to help reduce health-care costs, but the brave new world also brings with it big challenges.
The medical device lobby group AdvaMed proclaimed 2017 the year of digital health. True to that sentiment, there's been significant movement over the past year in the space, including large multinationals entering the digital-health market and efforts by US FDA, and global regulators, to ease oversight of digital-health products.
Meanwhile, observers of the space say we are approaching a period of exponential adoption of health apps due to a...
The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.
EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.
The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.
